EN HU

Pintér Tamás Bence

Pintér Tamás Bence

Publication list

2026
1.
Enyedi, E. E., Szabó, A. Á., Pintér, T. B., Mányiné Siket, I., Pluhár, A., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Albumin-Bound Fatty Acids Modulate Endogenous Angiotensin-Converting Enzyme (ACE) Inhibition.
Biomedicines. 14 (1), 1-19, (article identifier: 103), 2026.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)
Q1 Medicine (miscellaneous) (2025)
2.
Tatai, O., Nagy, S., Nguyen, T. H. T., Lajszné Tóth, B., Antal-Szalmás, P., Mányiné Siket, I., Pintér, T. B., Fagyas, M., Papp, Z., Csécsei, P., Lehoczki, A., Szappanos, Á., Ungvári, Z., Molnár, T., Tóth, A.: Tissue-specific autoantibody signatures reveal immune alterations undetected by routine serology in long COVID.
GeroScience. 48 (3), 3623-3647, 2026.
Journal metrics:
Q1 Aging (2025)
Q1 Cardiology and Cardiovascular Medicine (2025)
D1 Complementary and Alternative Medicine (2025)
D1 Geriatrics and Gerontology (2025)
D1 Veterinary (miscellaneous) (2025)
2025
3.
Szabó, A. Á., Enyedi, E. E., Pintér, T. B., Mányiné Siket, I., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Interference-Free Measurement of Urinary Angiotensin-Converting Enzyme (ACE) Activity: Diagnostic and Therapeutic Monitoring Implications.
Biomedicines. 13 (10), 1-17, (article identifier: 2528), 2025.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
2024
4.
Szabó, A. Á., Enyedi, E. E., Altorjay, I., Hajnal, P., Pintér, T. B., Mányiné Siket, I., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Get reliable laboratory findings: how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?.
Clin. Chem. Lab. Med. 62 (7), 1393-1401, 2024.
Journal metrics:
Q1 Biochemistry (medical)
Q2 Clinical Biochemistry
Q1 Medicine (miscellaneous)
DEENK University of Debrecen
© 2012 University of Debrecen